NCCN CNS tumor guidelines update for 2023

Journal Article NCCN CNS tumor guidelines update for 2023 Get access Burt Nabors, Burt Nabors Department of Neurology, Division of Neuro-oncology; Departments of Neurology and Neurosurgery, O'Neal Comprehensive Cancer Center, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama Corresponding Author: Burt Nabors, MD, Department of Neurology, Division of Neuro-oncology; Departments of Neurology and Neurosurgery, O'Neal Comprehensive Cancer Center, Heersink School of Medicine, University of Alabama at Birmingham, 510 20th Street South, FOT 1020, Birmingham, AL 35294, USA (bnabors@uab.edu) https://orcid.org/0000-0001-5926-2230 Search for other works by this author on: Oxford Academic PubMed Google Scholar Jana Portnow, Jana Portnow Department of Medical Oncology and Research Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California Search for other works by this author on: Oxford Academic PubMed Google Scholar Jona Hattangadi-Gluth, Jona Hattangadi-Gluth Moores Cancer Center, University of California San Diego, San Diego, California Search for other works by this author on: Oxford Academic PubMed Google Scholar Craig Horbinski Craig Horbinski Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois https://orcid.org/0000-0001-8340-9992 Search for other works by this author on: Oxford Academic PubMed Google Scholar Neuro-Oncology, Volume 25, Issue 12, December 2023, Pages 2114–2116, https://doi.org/10.1093/neuonc/noad169 Published: 14 September 2023 Article history Published: 14 September 2023 Corrected and typeset: 25 September 2023